Cargando…

Uncovering the genetic links of SARS‐CoV‐2 infections on heart failure co‐morbidity by a systems biology approach

AIMS: The co‐morbidities contribute to the inferior prognosis of COVID‐19 patients. Recent reports suggested that the higher co‐morbidity rate between COVID‐19 and heart failure (HF) leads to increased mortality. However, the common pathogenic mechanism between them remained elusive. Here, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ge, Cui, Xiaolin, Zhang, Li, Liu, Gangqiong, Zhu, Xiaodan, Shangguan, Jiahong, Zhang, Wenjing, Zheng, Yingying, Zhang, Hui, Tang, Junnan, Zhang, Jinying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349450/ https://www.ncbi.nlm.nih.gov/pubmed/35727093 http://dx.doi.org/10.1002/ehf2.14003

Ejemplares similares

Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability
por: Zhang, Ge, et al.
Publicado: (2023)

New Insights and Novel Therapeutic Potentials for Macrophages in Myocardial Infarction
por: Zhang, Zenglei, et al.
Publicado: (2021)

The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus
por: Xu, Shuai, et al.
Publicado: (2022)

Inhibition of Autophagy Prevents Panax Notoginseng Saponins (PNS) Protection on Cardiac Myocytes Against Endoplasmic Reticulum (ER) Stress-Induced Mitochondrial Injury, Ca(2+) Homeostasis and Associated Apoptosis
por: Chen, Jun, et al.
Publicado: (2021)

Amelioration of atherosclerosis in apolipoprotein E-deficient mice by combined RNA interference of lipoprotein-associated phospholipase A(2) and YKL-40
por: Zhang, Hui, et al.
Publicado: (2018)

Neprilysin Inhibitor–Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice
por: Zhang, Hui, et al.
Publicado: (2019)

Panax Notoginseng Saponins Protect Cardiac Myocytes Against Endoplasmic Reticulum Stress and Associated Apoptosis Through Mediation of Intracellular Calcium Homeostasis
por: Chen, Jun, et al.
Publicado: (2019)

The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy
por: Lu, Yongzheng, et al.
Publicado: (2022)

Differential expression profiles of plasma exosomal microRNAs in dilated cardiomyopathy with chronic heart failure
por: Zhang, Li, et al.
Publicado: (2023)

Circulating exosomes repair endothelial cell damage by delivering miR‐193a‐5p
por: Cao, Chang, et al.
Publicado: (2020)

Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations: a retrospective, cross-sectional study
por: Webster, Gregory, et al.
Publicado: (2006)

Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae
por: Li, Shao, et al.
Publicado: (2010)

Systemic immune‐inflammation index as a prognostic marker for advanced chronic heart failure with renal dysfunction
por: Wang, Zeyu, et al.
Publicado: (2022)

Co-Morbidities of Interstitial Cystitis
por: Chelimsky, Gisela, et al.
Publicado: (2012)

Uncovering Genomic Causes of Co-Morbidity in Epilepsy: Gene-Driven Phenotypic Characterization of Rare Microdeletions
por: Kasperavičiūtė, Dalia, et al.
Publicado: (2011)

Heart failure in primary care: co-morbidity and utilization of health care resources
por: Carmona, Montserrat, et al.
Publicado: (2013)

Heart Repair Using Nanogel-Encapsulated Human Cardiac Stem Cells in Mice and Pigs with Myocardial Infarction
por: Tang, Junnan, et al.
Publicado: (2017)

The Epidemiology of Vertigo, Dizziness, and Unsteadiness and Its Links to Co-Morbidities
por: Bisdorff, Alexandre, et al.
Publicado: (2013)

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018)

Common Co-Morbidities in Heart Failure – Diabetes, Functional Mitral Regurgitation and Sleep Apnoea
por: Stewart Coats, Andrew J.
Publicado: (2019)

Heart failure ejection fraction class conversions: impact of biomarkers, co‐morbidities, and pharmacotherapy
por: Lorenzo, Christian J., et al.
Publicado: (2022)

Evaluation of the Effect of Heart Failure Reversal Therapy on Exercise Capacity in Patients with Chronic Heart Failure and the Association with Co-morbidities
por: Sane, R
Publicado: (2020)

Smooth muscle cell fate decisions decipher a high-resolution heterogeneity within atherosclerosis molecular subtypes
por: Zhang, Ge, et al.
Publicado: (2022)

Congestive Heart Failure 30-Day Readmission: Descriptive Study of Demographics, Co-morbidities, Heart Failure Knowledge, and Self-Care
por: Madanat, Luai, et al.
Publicado: (2021)

12(S)‐hydroxyeicosatetraenoic acid impairs vascular endothelial permeability by altering adherens junction phosphorylation levels and affecting the binding and dissociation of its components in high glucose‐induced vascular injury
por: Wang, Xiaofang, et al.
Publicado: (2018)

Indirect comparison of novel Oral anticoagulants among Asians with non-Valvular atrial fibrillation in the real world setting: a network meta-analysis
por: Zhang, Jianchao, et al.
Publicado: (2019)

Relative contribution of risk factors/co‐morbidities to heart failure pathogenesis: interaction with ejection fraction
por: Giamouzis, Grigorios, et al.
Publicado: (2020)

Performance of a multisensor implantable defibrillator algorithm for heart failure monitoring related to co‐morbidities
por: Santobuono, Vincenzo Ezio, et al.
Publicado: (2023)

Screening and Bioinformatics Analysis of Crucial Gene of Heart Failure and Atrial Fibrillation Based on GEO Database
por: Zhuang, Yuansong, et al.
Publicado: (2022)

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
por: von Haehling, Stephan, et al.
Publicado: (2010)

KSHF Guidelines for the Management of Acute Heart Failure: Part III. Specific Management of Acute Heart Failure According to the Etiology and Co-morbidity
por: Kim, Min-Seok, et al.
Publicado: (2018)

Small but significant: Insights and new perspectives of exosomes in cardiovascular disease
por: Zhang, Jianchao, et al.
Publicado: (2020)

Psoriasis and Co-morbidity
por: AMIN, Mina, et al.
Publicado: (2020)

Impact of sex differences in co‐morbidities and medication adherence on outcome in 25 776 heart failure patients
por: Gürgöze, Muhammed T., et al.
Publicado: (2020)

Integrating Pharmacokinetics Study, Network Analysis, and Experimental Validation to Uncover the Mechanism of Qiliqiangxin Capsule Against Chronic Heart Failure
por: Zhang, Yu, et al.
Publicado: (2019)

What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?
por: Humphreys, Jenny, et al.
Publicado: (2016)

A deep learning system for heart failure mortality prediction
por: Li, Dengao, et al.
Publicado: (2023)

Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co‐morbid burden in acute decompensated heart failure
por: Kayama, Kiyomi, et al.
Publicado: (2021)

The effect of three major co‐morbidities on quality of life and outcome of patients with heart failure with reduced ejection fraction
por: Benes, Jan, et al.
Publicado: (2021)

Uncovering the complexities of biological structures with network-based learning: An application in SARS-CoV-2
por: Faghri, Faraz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c60vv6c9nts4mbn70fm3jpka1a